FDA Accepts Application for a New HS Treatment FDA Accepts Application for a New HS Treatment

Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology Source Type: news